Concourse Financial Group Securities’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-500
Closed -$4.12K 2251
2024
Q3
$4.08K Buy
+500
New +$3.3K ﹤0.01% 1896
2021
Q4
Sell
-75
Closed -$2.01K 2376
2021
Q3
$2K Sell
75
-63
-46% -$1.79K ﹤0.01% 2207
2021
Q2
$4K Buy
138
+39
+39% +$1.18K ﹤0.01% 2076
2021
Q1
$3K Buy
+99
New +$2.9K ﹤0.01% 2047
2020
Q4
Sell
-205
Closed -$3.82K 2286
2020
Q3
$3K Buy
205
+56
+38% +$965 ﹤0.01% 1919
2020
Q2
$3K Buy
149
+60
+67% +$1.06K ﹤0.01% 1805
2020
Q1
$1K Buy
+89
New +$2.15K ﹤0.01% 1998
2019
Q2
Sell
-125
Closed -$2.97K 2253
2019
Q1
$3K Hold
125
﹤0.01% 1892
2018
Q4
$2K Hold
125
﹤0.01% 1891
2018
Q3
$3K Buy
+125
New +$2.86K ﹤0.01% 1495

Other funds holding BHC

Concourse Financial Group Securities's BHC Position: Q4 2024 in Review

Concourse Financial Group Securities sold out of Bausch Health (BHC) in Q4 2024, closing a stake of 500 shares — an estimated $4.12K sold.

Concourse Financial Group Securities first reported a position in BHC in Q3 2018 and held it in 10 quarters. The position peaked at $4.08K in Q3 2024. 225 funds tracked by Wall St. Rank hold BHC as of Q4 2024.

  • Concourse Financial Group Securities reported no remaining Bausch Health position as of Q4 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 500 Bausch Health shares in Q4 2024, an estimated $4.12K.
  • Concourse Financial Group Securities first reported a position in Bausch Health in Q3 2018 and held it in 10 quarters.
  • Concourse Financial Group Securities's Bausch Health position peaked at $4.08K in Q3 2024.
  • 225 funds tracked by Wall St. Rank held Bausch Health as of Q4 2024.

Based on Concourse Financial Group Securities's 13F filing for Q4 2024, filed 13 Feb 2025.